PHILADELPHIA, March 8, 2012 /PRNewswire/ -- Aberdeen Australia Equity Fund, Inc. (NYSE AMEX: IAF) (the "Fund"), a closed-end equity fund, announced today that it will pay a quarterly distribution of US 28 cents per share on April 13, 2012 to all shareholders of record as of March 30, 2012. The Fund has a managed distribution policy of paying quarterly distributions at an annual rate, set once a year, that is a percentage of the rolling average of the Fund's prior four quarter-end net asset values. In March 2012, the Board of Directors determined that the rolling distribution rate would be 10% for the 12 months commencing with the distribution payable in April 2012. This policy will be subject to regular review by the Fund's Board of Directors. The distributions will be made from current income, supplemented by realized capital gains and, to the extent necessary, paid-in capital. For the 12 months to February 29, 2012, the Fund has paid total distributions amounting to $1.15 per share. The composition of distributions paid by the Fund since the beginning of the Fund's fiscal year, November 1, 2011, will be estimated through the payment date, and announced at the time of payment of the distribution. The Fund is managed by Aberdeen Asset Management Asia Limited and advised by Aberdeen Asset Management Limited. The Fund's shares trade on the NYSE AMEX under the symbol "IAF". You should not draw any conclusions about the Fund's investment performance from the amount of this distribution or from the terms of the Fund's Plan. Closed-end funds have a one-time initial public offering and then are subsequently traded on the secondary market through one of the stock exchanges. The investment return and principal value will fluctuate so that an investor's shares may be worth more or less than the original cost. Shares of closed-end funds may trade above (a premium) or below (a discount) the net asset value (NAV) of the fund's portfolio. There is no assurance that a fund will achieve its investment objective. Past performance does not guarantee future results.